Mateusz Gładysz FESSH prep

Categories

Category · 5 questions

Dupuytren disease

Pathophysiology, prognosis, and operative versus needle approaches.

  1. FESSH-002 Intermediate prognosis recurrence

    Dupuytren's diathesis

    Regarding the revised Dupuytren's diathesis (Hindocha et al., 2006), which describes prognostic indicators for risk of disease recurrence after surgical management:

  2. FESSH-048 Advanced CORD I efficacy, five year recurrence after needle fasciotomy versus limited fasciectomy, the DISC trial, firebreak dermofasciectomy evidence, the 2020 European withdrawal of collagenase

    Contemporary treatment of Dupuytren contracture: collagenase, needle fasciotomy and fasciectomy

    Regarding the evidence for contemporary treatments of Dupuytren contracture:

  3. FESSH-061 Basic Myofibroblast, spiral cord and the neurovascular bundle, diabetes association, distribution across the rays, Wnt pathway susceptibility loci

    Dupuytren disease: pathobiology, cord anatomy and risk factors

    Regarding the pathobiology, cord anatomy and risk factors of Dupuytren disease:

  4. FESSH-074 Intermediate Pooled rates of digital nerve injury and complex regional pain syndrome, neurovascular risk in recurrent disease, systemic risk by type of anaesthesia, consensus definitions of recurrence

    Complications of fasciectomy for Dupuytren disease

    Regarding complications of fasciectomy for Dupuytren disease:

  5. FESSH-100 Basic

    Staging of Dupuytren disease and indications for intervention

    Regarding the staging of Dupuytren disease and the indications for intervention: